BRCAmutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists-Reference-Cited by-同舟云学术

BRCAmutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists

Published:2019-03 Issue:S2 Volume:15 Page:20-31
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Kwong Ava¹²³⁴,Cheng Ka‐Leung Danny¹²,Hsue Chan‐Chee Victor⁵,Hui Sze‐Ki⁶,Leung Ching‐Yu Roland²,Leung Kwong‐Chuen Angus⁵,Ngan Kai‐Cheong Roger⁷,Soong Sung Inda⁸

Affiliation:

1. Department of SurgeryThe University of Hong Kong Hong Kong

2. Department of MedicineThe University of Hong Kong Hong Kong

3. Cancer Genetics CenterHong Kong Sanatorium and Hospital Hong Kong

4. Hong Kong Hereditary Breast Cancer Family Registry Hong Kong

5. Clinical OncologistPrivate Practice Hong Kong

6. Department of Obstetrics and GynaecologyPrincess Margaret Hospital Hong Kong

7. Department of Clinical OncologyGleneagles Hospital Hong Kong

8. Department of Clinical OncologyPamela Youde Nethersole Eastern Hospital Hong Kong

Funder

AstraZeneca Limited

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13116

Reference68 articles.

1. The biology of ovarian cancer: new opportunities for translation

2. New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential

3. Latest research and treatment of advanced-stage epithelial ovarian cancer

4. Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer

5. The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort;Cancers;2024-09-03

2. Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology;Frontiers in Oncology;2022-07-18

3. Awareness of genetic counseling and genetic testing for hereditary gynecologic cancers among Korean healthcare providers: A survey;Journal of Genetic Counseling;2021-10-21